ATE108799T1 - Konjugate von in position c-3 eine detergens- kette enthaltenden vinca-derivaten. - Google Patents

Konjugate von in position c-3 eine detergens- kette enthaltenden vinca-derivaten.

Info

Publication number
ATE108799T1
ATE108799T1 AT89400334T AT89400334T ATE108799T1 AT E108799 T1 ATE108799 T1 AT E108799T1 AT 89400334 T AT89400334 T AT 89400334T AT 89400334 T AT89400334 T AT 89400334T AT E108799 T1 ATE108799 T1 AT E108799T1
Authority
AT
Austria
Prior art keywords
conjugates
derivatives containing
chain
detergent
vinca
Prior art date
Application number
AT89400334T
Other languages
English (en)
Inventor
Rao Ksp Siva Bhushana
Jean-Paul Dejonghe
Marie-Paule Collard
Andre Trouet
Original Assignee
Wallone Region
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wallone Region filed Critical Wallone Region
Application granted granted Critical
Publication of ATE108799T1 publication Critical patent/ATE108799T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT89400334T 1988-02-08 1989-02-07 Konjugate von in position c-3 eine detergens- kette enthaltenden vinca-derivaten. ATE108799T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8801439A FR2626882B1 (fr) 1988-02-08 1988-02-08 Conjugues de derives de vinca comportant une chaine detergente en position c-3

Publications (1)

Publication Number Publication Date
ATE108799T1 true ATE108799T1 (de) 1994-08-15

Family

ID=9363041

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89400334T ATE108799T1 (de) 1988-02-08 1989-02-07 Konjugate von in position c-3 eine detergens- kette enthaltenden vinca-derivaten.

Country Status (8)

Country Link
US (1) US5024835A (de)
EP (1) EP0328446B1 (de)
JP (1) JP2930965B2 (de)
AT (1) ATE108799T1 (de)
CA (1) CA1336119C (de)
DE (1) DE68916820T2 (de)
ES (1) ES2057157T3 (de)
FR (1) FR2626882B1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4122210C2 (de) * 1991-07-04 1999-04-01 Deutsches Krebsforsch Konjugate aus tumoraktiver Verbindung und Serumalbumin sowie Verfahren zu deren Herstellung und ihre Verwendung
US5379254A (en) * 1992-10-20 1995-01-03 National Semiconductor Corporation Asymmetrical alternate metal virtual ground EPROM array
US5866679A (en) * 1994-06-28 1999-02-02 Merck & Co., Inc. Peptides
US6143864A (en) * 1994-06-28 2000-11-07 Merck & Co., Inc. Peptides
US5599686A (en) * 1994-06-28 1997-02-04 Merck & Co., Inc. Peptides
AU694546C (en) * 1994-08-19 2001-09-06 La Region Wallonne Compounds, pharmaceutical composition and diagnostic device comprising same and their use
DE4433890C2 (de) * 1994-09-22 1999-02-18 Deutsches Krebsforsch Konjugat aus einem Wirkstoff und einem nicht als körperfremd angesehenen, nativen Protein
JPH11511137A (ja) * 1995-08-08 1999-09-28 ファイブロゲン，インコーポレーテッド コラーゲンの過剰生産に関係した疾患を治療するためのｃ−プロテイナーゼ阻害剤
US5998362A (en) * 1996-09-12 1999-12-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US5948750A (en) * 1996-10-30 1999-09-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US6127333A (en) * 1997-07-10 2000-10-03 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US6391305B1 (en) 1997-09-10 2002-05-21 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
KR100580137B1 (ko) * 1997-12-02 2006-05-16 머크 앤드 캄파니 인코포레이티드 전립선 암 치료에 유용한 접합체 및 이를 포함하는 약제학적 조성물
ZA9810974B (en) * 1997-12-02 1999-06-03 Merck & Co Inc Conjugates useful in the treatment of prostate cancer
US20040081659A1 (en) * 1997-12-02 2004-04-29 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
AU5240999A (en) * 1998-07-31 2000-02-21 Goldsmith Seeds Inc. Trimeric and polymeric alkaloids
US6174858B1 (en) 1998-11-17 2001-01-16 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US7425541B2 (en) * 1998-12-11 2008-09-16 Medarex, Inc. Enzyme-cleavable prodrug compounds
CA2413149A1 (en) 2000-06-14 2001-12-20 Medarex, Inc. Prodrug compounds with isoleucine
JP2004527727A (ja) * 2000-07-05 2004-09-09 シーアールティ ホールディングス、インク 電磁気放射起動プラズマ反応炉
US20030232760A1 (en) * 2001-09-21 2003-12-18 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US8946387B2 (en) * 2002-08-14 2015-02-03 Macrogenics, Inc. FcγRIIB specific antibodies and methods of use thereof
US8968730B2 (en) * 2002-08-14 2015-03-03 Macrogenics Inc. FcγRIIB specific antibodies and methods of use thereof
US8193318B2 (en) * 2002-08-14 2012-06-05 Macrogenics, Inc. FcγRIIB specific antibodies and methods of use thereof
US8044180B2 (en) * 2002-08-14 2011-10-25 Macrogenics, Inc. FcγRIIB specific antibodies and methods of use thereof
US8187593B2 (en) * 2002-08-14 2012-05-29 Macrogenics, Inc. FcγRIIB specific antibodies and methods of use thereof
US8530627B2 (en) * 2002-08-14 2013-09-10 Macrogenics, Inc. FcγRIIB specific antibodies and methods of use thereof
US20090017023A1 (en) * 2002-08-14 2009-01-15 Macrogenics, Inc. FcGammaRIIB Specific Antibodies and Methods of Use Thereof
WO2004063351A2 (en) * 2003-01-09 2004-07-29 Macrogenics, Inc. IDENTIFICATION AND ENGINEERING OF ANTIBODIES WITH VARIANT Fc REGIONS AND METHODS OF USING SAME
US7960512B2 (en) * 2003-01-09 2011-06-14 Macrogenics, Inc. Identification and engineering of antibodies with variant Fc regions and methods of using same
US20050148534A1 (en) * 2003-09-22 2005-07-07 Castellino Angelo J. Small molecule compositions and methods for increasing drug efficiency using compositions thereof
CN1878568A (zh) * 2003-11-05 2006-12-13 盘林京有限公司 Cdim结合抗体的增强的b细胞细胞毒性
EP1761563A4 (de) * 2004-05-10 2008-05-14 Macrogenics Inc HUMANISIERTE FC gamma SPEZIFISCHE ANTIKÖRPER UND VERFAHREN ZU DEREN ANWENDUNG
CA2587766A1 (en) * 2004-11-10 2007-03-01 Macrogenics, Inc. Engineering fc antibody regions to confer effector function
AU2006279945B2 (en) * 2005-08-10 2012-04-12 Macrogenics, Inc. Identification and engineering of antibodies with variant FC regions and methods of using same
WO2007106707A2 (en) * 2006-03-10 2007-09-20 Macrogenics, Inc. Identification and engineering of antibodies with variant heavy chains and methods of using same
WO2008105886A2 (en) * 2006-05-26 2008-09-04 Macrogenics, Inc. HUMANIZED FCγRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
EP2032159B1 (de) * 2006-06-26 2015-01-07 MacroGenics, Inc. Kombination aus fcgammariib-antikörpern und cd20-spezifischen antikörpern sowie verwendungsverfahren dafür
EP2029173B1 (de) 2006-06-26 2016-07-20 MacroGenics, Inc. Fc-riib-spezifische antikörper und verfahren zu ihrer anwendung
US20080112961A1 (en) * 2006-10-09 2008-05-15 Macrogenics, Inc. Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same
US8652466B2 (en) 2006-12-08 2014-02-18 Macrogenics, Inc. Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting
SG189730A1 (en) 2008-04-02 2013-05-31 Macrogenics Inc Her2/neu-specific antibodies and methods of using same
US8669349B2 (en) 2008-04-02 2014-03-11 Macrogenics, Inc. BCR-complex-specific antibodies and methods of using same
EP2282770B1 (de) * 2008-06-04 2018-03-07 MacroGenics, Inc. Antikörper mit veränderter bindung an fcrn und verwendungsverfahren dafür
WO2011044368A1 (en) 2009-10-07 2011-04-14 Macrogenics, Inc. Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use
HUE045487T2 (hu) 2010-03-04 2019-12-30 Macrogenics Inc B7-H3-ra reaktív antitestek, immunológiailag aktív fragmenseik és alkalmazásaik
US8802091B2 (en) 2010-03-04 2014-08-12 Macrogenics, Inc. Antibodies reactive with B7-H3 and uses thereof
US9487587B2 (en) 2013-03-05 2016-11-08 Macrogenics, Inc. Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
CN107206101B (zh) * 2014-12-03 2021-06-25 基因泰克公司 季铵化合物及其抗体-药物缀合物
EP3442574A4 (de) 2016-04-15 2019-12-11 MacroGenics, Inc. Neuartige b7-h3-bindende moleküle, antikörper-wirkstoff-konjugate davon und verfahren zur verwendung davon

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU83822A1 (fr) * 1981-12-08 1983-09-01 Omnichem Sa Derives n-(vinblastinoyl-23)d'acides amines,leur preparation et leur application therapeutique
OA06421A (fr) * 1980-06-10 1981-09-30 Omnium Chimique Sa Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides.
FI820020L (fi) * 1981-01-12 1982-07-13 Lilly Industries Ltd Immunoglobulinkonjugater
EP0121388B1 (de) * 1983-03-30 1990-06-13 Lilly Industries Limited Immunoglobulinkonjugate
EP0124502B1 (de) * 1983-04-29 1991-06-12 OMNICHEM Société anonyme Konjugierte Vinblastin-Verbindungen und ihre Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
EP0232693A3 (de) * 1985-12-16 1988-04-06 La Region Wallonne Konjugate des Vinblastins und seiner Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
FR2592883B1 (fr) * 1986-01-13 1988-09-16 Ire Celltarg Sa Derives de vinblastine et composition pharmaceutique les contenant
JPH075608B2 (ja) * 1986-01-13 1995-01-25 イ−ル−セルタ−ク ソシエテ アノニム ビンブラスチン誘導体

Also Published As

Publication number Publication date
JPH02152992A (ja) 1990-06-12
US5024835A (en) 1991-06-18
EP0328446B1 (de) 1994-07-20
FR2626882A1 (fr) 1989-08-11
CA1336119C (fr) 1995-06-27
FR2626882B1 (fr) 1991-11-08
JP2930965B2 (ja) 1999-08-09
ES2057157T3 (es) 1994-10-16
DE68916820T2 (de) 1995-03-09
DE68916820D1 (de) 1994-08-25
EP0328446A1 (de) 1989-08-16

Similar Documents

Publication Publication Date Title
DE68916820D1 (de) Konjugate von in Position C-3 eine Detergens-Kette enthaltenden Vinca-Derivaten.
IL89503A0 (en) Taxol derivatives,pharmaceutical compositions containing the same and process for the preparation thereof
SG47430A1 (en) Pharmaceutical and other dosage forms
IT1144601B (it) Derivati della vinblastina procedimento per la loro preparazione e composizioni farmaceutiche contenenti tali derivati
ATE375363T1 (de) Derivate des wachstumshormons und verwandte proteine
DE3751808D1 (en) N-substituierte thioakylphenothiazine
ES2063326T3 (es) Conjugados de polimixina.
HUT44267A (en) Process for preparing new organic platinum complexes
ZA941198B (en) Highly concentrated TCF pharmaceutical preparations
JPS5533497A (en) Silaasubstituted 1*44dihydropyridine derivative
DK369287D0 (da) Immunotoksiner og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem
IT8919964A0 (it) Proteine inibenti i ribosomi e loro derivati.
HUT53125A (en) Process for producing peptides with anticoagulant activity
FR2592883A1 (fr) Derives de vinblastine et composition pharmaceutique les contenant
ATE96331T1 (de) Fr115224 enthaltende zusammensetzung fuer eine parenterale verabreichung.
ATE137487T1 (de) Komplexe, enthaltend s(+)-phenyl-alkansäuren und alpha-hydroxy-alkansäuren
DE58907569D1 (de) Isomere Trimethylbicyclo[4.3.0]nonan-Derivate.
ZA882762B (en) Novel derivative of d.25,process for its preparation,its use as an immunostimulant,and pharmaceutical compositions containing the derivative
IT1241459B (it) Composizioni farmaceutiche per la somministrazione rettale di calcitonina
IT8705187A0 (it) Procedimento per preparare coniugati di metalloproteine e nuovi derivati dei coniugati stessi.
IT8919648A0 (it) Derivati dell'indolo, procedimento per la loro preparazione e mezzi farmaceutici contenenti tali composti.
ES1003757U (es) Asa amovible para envases de carton y analogos.
IT1243778B (it) Derivati salini dell'acido tauroursodesossicolico, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT217249Z2 (it) Articolo per corrispondenza convertibile in busta
ATE31623T1 (de) Injizierbare zusammensetzungen von bbm-928a.